Beyond Carb Counting: Boost’s Evolution — and the Limits of “Fully Closed Loop”
An update on Boost, how it helps remove carb counting, and the techniques and mechanisms we’ve used to try and get there.
Diabetes
Bolt AI into your loop and you might just have become a medical device manufacturer
Embedded AI is starting to appear in open source AID systems, offered as copy and paste, bring your own key, or a service the project runs. A year of measuring these models says the clinical risk is much the same in all three. The regulatory position is not, and the intuition about which is safest runs backwards.
A world of pure imagination: AI, diabetes and the data we can’t get at
Search the app stores for diabetes and AI and you will find a remarkable number of applications doing exactly one thing. You point a camera […]
Why is the cheese sandwich the downfall of AI carb counting, even with “3D scanning”?
A slightly rhetorical question, I’ll admit, but a pertinent one. Once again, I have been trying out the latest (read most heavily pushed on Facebook […]
100% Insulin Independence: Why Eledon’s Breakthrough is a Pillar, Not a Cure
Eledon Pharmaceuticals recently achieved 100% insulin independence in an early-phase islet transplant trial using its anti-CD40L drug, tegoprubart. It’s a massive step forward in transplant immunology that avoids the toxicity of standard drugs. But why isn’t it a cure yet, and how does it fit into the actual blueprint of a functional cure?
Explore a Decade of Diabetes Insights with Diabettech AI
After 10+ years of documenting the diabetes landscape, Diabettech is launching diabettech.ai—a custom research tool designed to help you navigate a decade’s worth of articles and reports. Powered by an LLM interface, this tool allows you to “interrogate” the site’s data to find specific answers on everything from cures to n=1 observations.
Key highlights of the beta launch:
Targeted Accuracy: Built to stick strictly to Diabettech articles and comments to minimize “hallucinations.”
Research-Focused: Optimized as a precision tool rather than a standard chatbot to provide relevant article links.
Sustainable Design: Privately funded and optimized for efficiency to manage resource costs and query speeds.
Ready to dive into the archives? Visit diabettech.ai to start your research and share your feedback on the beta experience.
Now We Know What a Type 1 Cure Could Look Like
The Type 1 cure is no longer theoretical. Human data now points to a blueprint: working cells, immune evasion, and durable immune modulation.
What If Type 1 Diabetes Was Treatable — If You Found It Early Enough?
For most of its history, type 1 diabetes (T1D) has been diagnosed late. By the time symptoms appear, the autoimmune destruction of pancreatic beta cells […]
ChatGPT Health: Promise, Practicality, and the Reality for People with Diabetes
Artificial intelligence has been hovering around diabetes care for a while now, usually wrapped in glossy demos and ambitious claims. Carb-counting apps that “just work”. […]
Beyond Snaq-qing. Digesting your glucose patterns.
I spent a long time discussing Snaq’s use of AI for food recognition in the previous article. In this one, I’m looking at what it […]